ETOCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ETO遺伝子サイレンサーは、ETO CRISPR/Cas9ノックアウトプラスミドとETODouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のETOCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ETO CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ETO CRISPR/Cas9 KOプラスミド (h) | sc-401755 | h | Gene Knockout | GFP | 0 | ||
ETO HDRプラスミド (h) | sc-401755-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ETO Double Nickaseプラスミド (h) | sc-401755-NIC | h | Gene Knockout | Puromycin | 0 | ||
ETO Double Nickaseプラスミド (h2) | sc-401755-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ETO CRISPR/Cas9 KOプラスミド (m) | sc-419484 | m | Gene Knockout | GFP | 0 | ||
ETO HDRプラスミド (m) | sc-419484-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ETO Double Nickaseプラスミド (m) | sc-419484-NIC | m | Gene Knockout | Puromycin | 0 | ||
ETO Double Nickaseプラスミド (m2) | sc-419484-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ETO-2 CRISPR/Cas9 KOプラスミド (h) | sc-404475 | h | Gene Knockout | GFP | 0 | ||
ETO-2 HDRプラスミド (h) | sc-404475-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ETO-2 Double Nickaseプラスミド (h) | sc-404475-NIC | h | Gene Knockout | Puromycin | 0 | ||
ETO-2 Double Nickaseプラスミド (h2) | sc-404475-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ETO-2 CRISPR/Cas9 KOプラスミド (m) | sc-419486 | m | Gene Knockout | GFP | 0 | ||
ETO-2 HDRプラスミド (m) | sc-419486-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ETO-2 Double Nickaseプラスミド (m) | sc-419486-NIC | m | Gene Knockout | Puromycin | 0 | ||
ETO-2 Double Nickaseプラスミド (m2) | sc-419486-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ETO CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ETO CRISPR Activationプラスミド (h) | sc-401755-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO CRISPR Activationプラスミド (h2) | sc-401755-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO Lentiviral Activation Particles (h) | sc-401755-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO Lentiviral Activation Particles (h2) | sc-401755-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO CRISPR Activationプラスミド (m) | sc-419484-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO CRISPR Activationプラスミド (m2) | sc-419484-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO Lentiviral Activation Particles (m) | sc-419484-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO Lentiviral Activation Particles (m2) | sc-419484-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 CRISPR Activationプラスミド (h) | sc-404475-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 CRISPR Activationプラスミド (h2) | sc-404475-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 Lentiviral Activation Particles (h) | sc-404475-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 Lentiviral Activation Particles (h2) | sc-404475-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 CRISPR Activationプラスミド (m) | sc-419486-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 CRISPR Activationプラスミド (m2) | sc-419486-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 Lentiviral Activation Particles (m) | sc-419486-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ETO-2 Lentiviral Activation Particles (m2) | sc-419486-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |